KG4:
Page 10 of the APO 8-K talks about the sale of Paivis Corp's APO common stock (I believe this is what the IR guy was referring to) to KJ Ventures, Ltd. for $1.00. Looks like they sold all of the stock (including all the current, contingent and future debts of APO Health). Seems like that should relieve the new mgt of Paivis of Procter & Gamble's lawsuit but I'm not 100% on that. APO Health Inc. (in whatever form they still exist) per the 8-K, is still "responsible for the resolution of these lawsuits plus the accrued costs of counsel fees in defense of these actions."
Market Data 
Markets 
AI
